Acetamide, N-(4-hydroxyphenyl)- | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Acetamide, N-(4-hydroxyphenyl)-
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Paracetamol

Contact Supplier

Chirogate is a professional Prostaglandin manufacturer.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

Contact Supplier

jdmfs-not-supported-m-2025-06-30

Acetamide, N-(4-hydroxyphenyl)-

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

257 API Suppliers, 80 USDMF, 21 CEP/COS, 16 JDMF, 9 EU WC, 108 KDMF, 108 NDC API, 33 Listed Suppliers, $ API Reference Price

257 API Suppliers
80 USDMF
21 CEP/COS
16 JDMF
9 EU WC
108 KDMF
108 NDC API
33 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

45 Drugs in Development

45 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2675 FDF Dossiers, 734 FDA Orange Book, 501 Europe, 292 Canada, 71 Australia, 402 South Africa, 675 Listed Dossiers

2675 FDF Dossiers
734 FDA Orange Book
501 Europe
292 Canada
71 Australia
402 South Africa
675 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUPPOSITORY;RECTAL - 120MG, SUPPOSITORY;RECTAL - 325MG, SUPPOSITORY;RECTAL - 650MG, SUPPOSITORY;RECTAL - 80MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 325MG;37.5MG, SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG;15MG, TABLET;ORAL - 300MG;30MG, TABLET;ORAL - 300MG;60MG, TABLET;ORAL - 325MG;5MG, TABLET;ORAL - 325MG;50MG;40MG, TABLET;ORAL - 300MG;60MG

SUPPOSITORY;RECTAL - 120MG
SUPPOSITORY;RECTAL - 325MG
SUPPOSITORY;RECTAL - 650MG
SUPPOSITORY;RECTAL - 80MG
CAPSULE;ORAL - 325MG;50MG;40MG;30MG
TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 250MG;250MG;65MG
TABLET;ORAL - 325MG;37.5MG
SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 300MG;15MG
TABLET;ORAL - 300MG;30MG
TABLET;ORAL - 300MG;60MG
TABLET;ORAL - 325MG;5MG
TABLET;ORAL - 325MG;50MG;40MG
TABLET;ORAL - 300MG;60MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Minakem, 1 Evonik, 13 Rochem International Inc, 32 SPI Pharma, 37 DKSH, 2 Pharm-RX Chemical, 14 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 21 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 4 ACG Worldwide, 19 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 1 Avesta Pharma, 44 BASF, 8 Beneo, 2 Bioplus Life Sciences, 6 CD Formulation, 6 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 2 Esteem Industries, 4 Finar, 17 Gangwal Chemicals, 2 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 27 Microlex e.U, 2 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 12 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 56 Roquette, 22 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

126 Fillers, Diluents & Binders, 88 Thickeners and Stabilizers, 73 Solubilizers, 64 Coating Systems & Additives, 60 Taste Masking, 59 Topical, 55 Direct Compression, 50 Disintegrants & Superdisintegrants, 45 Granulation, 43 Parenteral, 39 Lubricants & Glidants, 38 Film Formers & Plasticizers, 35 Controlled & Modified Release, 28 Chewable & Orodispersible Aids, 27 Emulsifying Agents, 24 Rheology Modifiers, 18 Co-Processed Excipients, 15 Surfactant & Foaming Agents, 12 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

126 Fillers, Diluents & Binders
88 Thickeners and Stabilizers
73 Solubilizers
64 Coating Systems & Additives
60 Taste Masking
59 Topical
55 Direct Compression
50 Disintegrants & Superdisintegrants
45 Granulation
43 Parenteral
39 Lubricants & Glidants
38 Film Formers & Plasticizers
35 Controlled & Modified Release
28 Chewable & Orodispersible Aids
27 Emulsifying Agents
24 Rheology Modifiers
18 Co-Processed Excipients
15 Surfactant & Foaming Agents
12 API Stability Enhancers
9 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 353 News #PharmaBuzz

2 Data Compilation #PharmaFlow
353 News #PharmaBuzz

GLOBAL SALES INFORMATION

94 US Medicaid Prescriptions, 403 Regulatory FDF Prices, 21 Annual Reports

94 US Medicaid Prescriptions
403 Regulatory FDF Prices
21 Annual Reports

MARKET PLACE

186 APIs, 95 FDF Dossiers

186 APIs
95 FDF Dossiers

PATENTS & EXCLUSIVITIES

41 US Patents, 1 US Exclusivities, 3 Health Canada Patents

41 US Patents
1 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 JP, 26 Others

1 EDQM
1 JP
26 Others

ANALYTICAL

2 BioAnalytical Methods, 8 Analytical Methods

2 BioAnalytical Methods
8 Analytical Methods

$ API Ref.Price (USD/KG) : 7 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 1Mallinckrodt Canada

02 2Mallinckrodt Pharmaceuticals Inc

filter Patent Reset all filters

3 All

01 12233924

02 12415403

03 12705733

filter Product Reset all filters

3 All

01 3Acetaminophen

filter Dosage Reset all filters

3 All

01 3Solution

filter Exp Date Reset all filters

3 All

01 12017-08-05

02 12021-06-06

03 12028-11-13

Granules Paracetamol

Product Main Page

01

Mallinckrodt Pharmaceuticals Inc

Paracetamol

Vietnam Medi-Pharm Expo

Not Confirmed

Mallinckrodt Pharmaceuticals Inc

Vietnam Medi-Pharm Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-06-06

Date Granted : 2011-05-24

Paracetamol

Brand Name : OFIRMEV

Patent Number : 2415403

Filing Date : 2001-06-06

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2021-06-06

Date Granted : 2011-05-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Mallinckrodt Canada

Paracetamol

Vietnam Medi-Pharm Expo

Not Confirmed

Mallinckrodt Canada

Vietnam Medi-Pharm Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-08-05

Date Granted : 2012-08-21

Paracetamol

Brand Name : OFIRMEV

Patent Number : 2233924

Filing Date : 1997-08-05

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2017-08-05

Date Granted : 2012-08-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Mallinckrodt Pharmaceuticals Inc

Paracetamol

Vietnam Medi-Pharm Expo

Not Confirmed

Mallinckrodt Pharmaceuticals Inc

Vietnam Medi-Pharm Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-11-13

Date Granted : 2015-02-03

Paracetamol

Brand Name : OFIRMEV

Patent Number : 2705733

Filing Date : 2008-11-13

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2028-11-13

Date Granted : 2015-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!